Southern Acids (M) Berhad

KLSE:SAB Voorraadrapport

Marktkapitalisatie: RM 424.5m

Southern Acids (M) Berhad Inkomsten in het verleden

Verleden criteriumcontroles 1/6

Southern Acids (M) Berhad's earnings have been declining at an average annual rate of -4%, while the Chemicals industry saw earnings growing at 6.5% annually. Revenues have been growing at an average rate of 11.4% per year. Southern Acids (M) Berhad's return on equity is 1.8%, and it has net margins of 0.7%.

Belangrijke informatie

-4.0%

Groei van de winst

-4.0%

Groei van de winst per aandeel

Chemicals Groei van de industrie8.9%
Inkomstengroei11.4%
Rendement op eigen vermogen1.8%
Nettomarge0.7%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Mar 03
Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

May 27
If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Apr 19
The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Feb 24
Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

Jan 13
Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

Dec 15
What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

Nov 24
Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

Opbrengsten en kosten

Hoe Southern Acids (M) Berhad geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

KLSE:SAB Opbrengsten, kosten en inkomsten (MYR Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 249466820
31 Mar 2492014820
31 Dec 23934-1790
30 Sep 2397711630
30 Jun 231,02528640
31 Mar 231,10733810
31 Dec 221,22269910
30 Sep 221,253801050
30 Jun 221,220861010
31 Mar 221,18194770
31 Dec 211,03974730
30 Sep 2191853710
30 Jun 2184644710
31 Mar 2174637690
31 Dec 2070440580
30 Sep 2069044590
30 Jun 2068244610
31 Mar 2066632620
31 Dec 1962724570
30 Sep 1960219570
30 Jun 1958819560
31 Mar 1960421560
31 Dec 1865829590
30 Sep 1871135570
30 Jun 1874732550
31 Mar 1876733560
31 Dec 1778741560
30 Sep 1778044550
30 Jun 1775247540
31 Mar 1774049510
31 Dec 1664637450
30 Sep 1657929450
30 Jun 1654823470
31 Mar 1650325470
31 Dec 1547927480
30 Sep 1549030480
30 Jun 1550730490
31 Mar 1553728500
31 Dec 1457529510
30 Sep 1458531510
30 Jun 1456538490
31 Mar 1454438480
31 Dec 1353939420

Kwaliteitswinsten: SAB has high quality earnings.

Groeiende winstmarge: SAB's current net profit margins (0.7%) are lower than last year (2.7%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: SAB's earnings have declined by 4% per year over the past 5 years.

Versnelling van de groei: SAB's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Winst versus industrie: SAB had negative earnings growth (-77.6%) over the past year, making it difficult to compare to the Chemicals industry average (24.4%).

Rendement op eigen vermogen

Hoge ROE: SAB's Return on Equity (1.8%) is considered low.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y